Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?

被引：3

作者：

Aisen, PS ^{[1
]}

机构：

[1] Georgetown Univ, Med Ctr, Memory Disorders Program, Washington, DC 20007 USA

来源：

NATURE CLINICAL PRACTICE NEUROLOGY | 2005年 / 1卷 / 01期

关键词：

Alzheimer's disease; cognition; mild cognitive impairment; rofecoxib;

D O I：

10.1038/ncpneuro0039

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：20 / 21

页数：2

共 6 条

[1] Inflammation and Alzheimer's disease [J].

Akiyama, H ;

Barger, S ;

Barnum, S ;

Bradt, B ;

Bauer, J ;

Cole, GM ;

Cooper, NR ;

Eikelenboom, P ;

Emmerling, M ;

Fiebich, BL ;

Finch, CE ;

Frautschy, S ;

Griffin, WST ;

Hampel, H ;

Hull, M ;

Landreth, G ;

Lue, LF ;

Mrak, R ;

Mackenzie, IR ;

McGeer, PL ;

O'Banion, MK ;

Pachter, J ;

Pasinetti, G ;

Plata-Salaman, C ;

Rogers, J ;

Rydel, R ;

Shen, Y ;

Streit, W ;

Strohmeyer, R ;

Tooyoma, I ;

Van Muiswinkel, FL ;

Veerhuis, R ;

Walker, D ;

Webster, S ;

Wegrzyniak, B ;

Wenk, G ;

Wyss-Coray, T .

NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421

[2] NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo [J].

Eriksen, JL ;

Sagi, SA ;

Smith, TE ;

Weggen, S ;

Das, P ;

McLendon, DC ;

Ozols, VV ;

Jessing, KW ;

Zavitz, KH ;

Koo, EH ;

Golde, TE .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :440-449

[3] Double placebo design in a prevention trial for Alzheimer's disease [J].

Martin, BK ;

Meinert, CL ;

Breitner, JCS .

CONTROLLED CLINICAL TRIALS, 2002, 23 (01) :93-99

[4] Vitamin E and donepezil for the treatment of mild cognitive impairment [J].

Petersen, RC ;

Thomas, RG ;

Grundman, M ;

Bennett, D ;

Doody, R ;

Ferris, S ;

Galasko, D ;

Jin, S ;

Kaye, J ;

Levey, A ;

Pfeiffer, E ;

Sano, M ;

van Dyck, CH ;

Thal, LJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2379-2388

[5] A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment [J].

Thal, LJ ;

Ferris, SH ;

Kirby, L ;

Block, GA ;

Lines, CR ;

Yuen, E ;

Assaid, C ;

Nessly, ML ;

Norman, BA ;

Baranak, CC ;

Reines, SA .

NEUROPSYCHOPHARMACOLOGY, 2005, 30 (06) :1204-1215

[6]

Walsh Sally, 2004, Expert Rev Neurother, V4, P793, DOI 10.1586/14737175.4.5.793

← 1 →